IPSOGEN Trademark

Trademark Overview


On Wednesday, February 20, 2002, a trademark application was filed for IPSOGEN with the United States Patent and Trademark Office. The USPTO has given the IPSOGEN trademark a serial number of 76373789. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 15, 2015. This trademark is owned by IPSOGEN. The IPSOGEN trademark is filed in the Pharmaceutical Products and Computer & Software Products & Electrical & Scientific Products categories with the following description:

[ Information processing devices, namely, computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information ]

Biological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain met...
ipsogen

General Information


Serial Number76373789
Word MarkIPSOGEN
Filing DateWednesday, February 20, 2002
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 15, 2015
Registration Number2958962
Registration DateTuesday, June 7, 2005
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 15, 2005

Trademark Statements


Goods and Services[ Information processing devices, namely, computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information ]
Goods and ServicesBiological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS, cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcinosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma, centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastroesophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eye metastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastrinoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, head and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-grade lymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer, meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma, orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarian peritoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic leukemia, prophylactic mastectomy, prostate cancer, prostatic intraepithelial neoplasia, PIN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone, sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-cell lymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia, Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, December 15, 2015
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQIAGEN GMBH
Party Type32 - New Owner After Registration
Legal Entity Type11 - Company
Address40724 HILDEN
DE

Party NameQIAGEN MARSEILLE
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMARSEILLE 13288 CED
FR

Party NameIPSOGEN
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressF-13273 Marseille Cedex 09
FR

Party NameIPSOGEN
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressF-13273 Marseille Cedex 09
FR

Party NameIPSOGEN
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressF-13273 Marseille Cedex 09
FR

Trademark Events


Event DateEvent Description
Friday, February 21, 2003LETTER OF SUSPENSION MAILED
Friday, March 15, 2002PAPER RECEIVED
Friday, March 15, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 15, 2002PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, June 14, 2002ASSIGNED TO EXAMINER
Monday, June 17, 2002UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Wednesday, June 19, 2002NON-FINAL ACTION MAILED
Friday, December 13, 2002PAPER RECEIVED
Friday, December 13, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 12, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 13, 2003CASE FILE IN TICRS
Thursday, October 23, 2003NON-FINAL ACTION MAILED
Monday, April 26, 2004PAPER RECEIVED
Monday, April 26, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 26, 2004Sec. 1(B) CLAIM DELETED
Friday, June 4, 2004NON-FINAL ACTION MAILED
Wednesday, September 22, 2004PAPER RECEIVED
Wednesday, September 22, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 7, 2004AMENDMENT FROM APPLICANT ENTERED
Tuesday, March 15, 2005PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2005REGISTERED-PRINCIPAL REGISTER
Thursday, July 14, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 14, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, July 14, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 7, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 19, 2004ASSIGNED TO LIE
Thursday, October 21, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 23, 2005NOTICE OF PUBLICATION
Thursday, June 2, 2011TEAS SECTION 8 & 15 RECEIVED
Monday, October 19, 2015TEAS SECTION 8 & 9 RECEIVED
Tuesday, December 15, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 15, 2015REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Tuesday, December 15, 2015REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Tuesday, December 15, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, December 15, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, September 24, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED